Gene Symbol | Gene ID | Gene Info |
---|---|---|
Msx2
|
ENSMUSG00000021469.8 | msh homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_53454867_53455049 | Msx2 | 18116 | 0.168813 | 0.75 | 5.2e-11 | Click! |
chr13_53455167_53455472 | Msx2 | 17755 | 0.169695 | 0.75 | 5.6e-11 | Click! |
chr13_53472733_53472954 | Msx2 | 231 | 0.933057 | 0.61 | 9.5e-07 | Click! |
chr13_53464667_53464842 | Msx2 | 8320 | 0.193599 | 0.43 | 1.2e-03 | Click! |
chr13_53475837_53476188 | Msx2 | 2938 | 0.259762 | 0.41 | 1.6e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_63747767_63748162 | 39.02 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr17_65961618_65962124 | 32.81 |
Ankrd12 |
ankyrin repeat domain 12 |
10521 |
0.14 |
chr3_69709128_69709981 | 31.43 |
Rpl32-ps |
ribosomal protein L32, pseudogene |
7839 |
0.17 |
chr14_123065129_123065306 | 30.74 |
AA536875 |
expressed sequence AA536875 |
21935 |
0.22 |
chr15_74194149_74194481 | 26.60 |
Gm15387 |
predicted gene 15387 |
99982 |
0.07 |
chr12_39301178_39301567 | 26.30 |
Gm18591 |
predicted gene, 18591 |
92480 |
0.08 |
chr3_6886780_6886981 | 25.44 |
Gm22074 |
predicted gene, 22074 |
90388 |
0.09 |
chr14_102205486_102205672 | 25.00 |
Gm22347 |
predicted gene, 22347 |
124082 |
0.06 |
chr15_44705846_44706012 | 24.38 |
Sybu |
syntabulin (syntaxin-interacting) |
41859 |
0.15 |
chr8_97477153_97477340 | 24.29 |
Gm5913 |
predicted gene 5913 |
48136 |
0.17 |
chr7_51784054_51784235 | 23.71 |
Gm29296 |
predicted gene 29296 |
11418 |
0.17 |
chr3_17789514_17789745 | 23.54 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
292 |
0.9 |
chr6_144367634_144367858 | 23.47 |
Sox5os2 |
SRY (sex determining region Y)-box 5, opposite strand 2 |
113479 |
0.07 |
chr16_16559677_16560060 | 23.25 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
122 |
0.97 |
chr15_88315161_88315318 | 22.89 |
B230214G05Rik |
RIKEN cDNA B230214G05 gene |
365 |
0.51 |
chr17_44398035_44398193 | 22.75 |
Gm49872 |
predicted gene, 49872 |
30211 |
0.23 |
chr3_6183428_6183711 | 22.59 |
Gm6162 |
predicted gene 6162 |
15745 |
0.23 |
chr14_123065358_123065532 | 21.73 |
AA536875 |
expressed sequence AA536875 |
22163 |
0.22 |
chr19_15803250_15803445 | 21.28 |
Gm50348 |
predicted gene, 50348 |
289 |
0.94 |
chr10_29143863_29144732 | 21.01 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr13_84448589_84449243 | 20.96 |
Gm26927 |
predicted gene, 26927 |
108803 |
0.07 |
chr13_99444397_99444879 | 20.74 |
Map1b |
microtubule-associated protein 1B |
171 |
0.95 |
chr1_94503928_94504626 | 20.60 |
Gm7895 |
predicted gene 7895 |
34390 |
0.22 |
chr10_25023823_25024169 | 20.52 |
Gm47715 |
predicted gene, 47715 |
23976 |
0.15 |
chr6_58855743_58855917 | 20.51 |
Herc3 |
hect domain and RLD 3 |
6999 |
0.22 |
chr15_26275989_26276253 | 20.20 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
32927 |
0.23 |
chr2_56539846_56540169 | 20.07 |
Mir195b |
microRNA 195b |
245804 |
0.02 |
chr3_11261156_11261347 | 19.99 |
Gm22547 |
predicted gene, 22547 |
106914 |
0.08 |
chr5_103161672_103161823 | 19.75 |
Mapk10 |
mitogen-activated protein kinase 10 |
44182 |
0.17 |
chr3_16938729_16939072 | 19.52 |
Gm26485 |
predicted gene, 26485 |
115588 |
0.07 |
chr2_62807459_62807865 | 19.48 |
Gm13569 |
predicted gene 13569 |
1525 |
0.44 |
chr2_63963866_63964056 | 19.36 |
Fign |
fidgetin |
134027 |
0.06 |
chr3_133496907_133497258 | 19.33 |
Tet2 |
tet methylcytosine dioxygenase 2 |
16400 |
0.18 |
chr10_19310105_19310477 | 19.26 |
Gm33056 |
predicted gene, 33056 |
19302 |
0.19 |
chr3_6886610_6886763 | 19.20 |
Gm22074 |
predicted gene, 22074 |
90582 |
0.09 |
chr2_179481364_179481534 | 19.10 |
Cdh4 |
cadherin 4 |
37216 |
0.18 |
chr13_36283484_36283656 | 19.10 |
Gm48766 |
predicted gene, 48766 |
31211 |
0.17 |
chr3_66746460_66746680 | 18.87 |
Gm6555 |
predicted gene 6555 |
135780 |
0.05 |
chr5_20227973_20228279 | 18.86 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
60 |
0.98 |
chr13_84757919_84758070 | 18.81 |
Gm26913 |
predicted gene, 26913 |
67053 |
0.14 |
chr3_83980001_83980856 | 18.78 |
Tmem131l |
transmembrane 131 like |
12200 |
0.25 |
chr1_78167977_78168321 | 18.56 |
Pax3 |
paired box 3 |
28689 |
0.2 |
chrX_58445733_58445903 | 18.49 |
Gm14645 |
predicted gene 14645 |
17743 |
0.26 |
chr4_26930175_26930410 | 18.41 |
Gm11904 |
predicted gene 11904 |
196217 |
0.03 |
chrX_109845362_109845527 | 18.24 |
Gm4991 |
predicted gene 4991 |
64777 |
0.15 |
chr5_16166576_16166763 | 18.06 |
Gm43490 |
predicted gene 43490 |
59540 |
0.14 |
chr10_25024228_25024379 | 18.04 |
Gm47715 |
predicted gene, 47715 |
24283 |
0.15 |
chr13_84752343_84752734 | 18.04 |
Gm26913 |
predicted gene, 26913 |
61597 |
0.15 |
chr4_21095762_21096024 | 18.03 |
Gm11871 |
predicted gene 11871 |
84953 |
0.1 |
chr14_79203440_79203814 | 18.00 |
Gm4632 |
predicted gene 4632 |
4437 |
0.18 |
chr6_6869733_6869901 | 17.99 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
1775 |
0.24 |
chr3_3832009_3832194 | 17.95 |
Gm2071 |
predicted gene 2071 |
2817 |
0.34 |
chr14_103613671_103614004 | 17.95 |
Slain1 |
SLAIN motif family, member 1 |
36391 |
0.16 |
chr10_66271002_66271188 | 17.87 |
1700023F02Rik |
RIKEN cDNA 1700023F02 gene |
16872 |
0.26 |
chr14_59737148_59737645 | 17.73 |
Gm19716 |
predicted gene, 19716 |
94848 |
0.07 |
chr2_146833312_146833528 | 17.67 |
Gm14114 |
predicted gene 14114 |
6312 |
0.24 |
chr3_20776940_20777107 | 17.60 |
Gm18491 |
predicted gene, 18491 |
7040 |
0.19 |
chr16_64068866_64069083 | 17.44 |
Gm49627 |
predicted gene, 49627 |
113844 |
0.07 |
chr6_87545316_87545628 | 17.28 |
Gm44198 |
predicted gene, 44198 |
12065 |
0.14 |
chr3_139885937_139886924 | 17.18 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr17_66869624_66870037 | 17.10 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chr14_75566269_75566669 | 17.02 |
Cby2 |
chibby family member 2 |
25480 |
0.19 |
chr12_49383638_49384096 | 17.00 |
Foxg1 |
forkhead box G1 |
860 |
0.39 |
chr4_48335165_48335701 | 16.91 |
Gm12435 |
predicted gene 12435 |
9797 |
0.22 |
chr17_16089653_16089809 | 16.88 |
Gm49778 |
predicted gene, 49778 |
73420 |
0.11 |
chr3_18454033_18454237 | 16.73 |
Gm30667 |
predicted gene, 30667 |
7119 |
0.22 |
chr9_122635277_122635496 | 16.72 |
Gm47134 |
predicted gene, 47134 |
12444 |
0.13 |
chr2_136670530_136670925 | 16.67 |
Gm36967 |
predicted gene, 36967 |
9234 |
0.23 |
chr16_71712007_71712158 | 16.66 |
Gm22797 |
predicted gene, 22797 |
48294 |
0.18 |
chr7_69572988_69573508 | 16.62 |
Gm44535 |
predicted gene 44535 |
6460 |
0.22 |
chr10_38103605_38103756 | 16.59 |
Gm31378 |
predicted gene, 31378 |
18381 |
0.22 |
chr2_107935313_107935699 | 16.58 |
Gm23439 |
predicted gene, 23439 |
48867 |
0.19 |
chr2_82847422_82847589 | 16.57 |
Fsip2 |
fibrous sheath-interacting protein 2 |
96129 |
0.09 |
chr3_6886348_6886531 | 16.57 |
Gm22074 |
predicted gene, 22074 |
90829 |
0.09 |
chr9_41378578_41379032 | 16.53 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2244 |
0.28 |
chr4_72382561_72382773 | 16.53 |
Gm11235 |
predicted gene 11235 |
159999 |
0.04 |
chr10_43023952_43024111 | 16.43 |
Gm47815 |
predicted gene, 47815 |
10962 |
0.22 |
chr3_13946274_13946476 | 16.42 |
Ralyl |
RALY RNA binding protein-like |
18 |
0.99 |
chr4_8810790_8810953 | 16.38 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
29451 |
0.24 |
chr6_112885019_112885538 | 16.25 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
55819 |
0.1 |
chr9_35402818_35403314 | 16.25 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
18062 |
0.15 |
chrX_22950779_22950930 | 16.20 |
Gm26131 |
predicted gene, 26131 |
88918 |
0.1 |
chr11_104106366_104106692 | 16.15 |
Crhr1 |
corticotropin releasing hormone receptor 1 |
26326 |
0.19 |
chr1_137373621_137374166 | 16.09 |
Gm23534 |
predicted gene, 23534 |
6646 |
0.26 |
chr7_79577344_79577537 | 16.05 |
Gm45168 |
predicted gene 45168 |
1628 |
0.22 |
chr12_86911376_86911690 | 16.04 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
26735 |
0.14 |
chr14_21252622_21252979 | 16.00 |
Adk |
adenosine kinase |
65325 |
0.13 |
chr4_72382144_72382349 | 15.96 |
Gm11235 |
predicted gene 11235 |
160420 |
0.04 |
chr2_132751607_132751822 | 15.95 |
Chgb |
chromogranin B |
29564 |
0.1 |
chr16_91140532_91140860 | 15.87 |
Gm49612 |
predicted gene, 49612 |
5220 |
0.12 |
chr5_97289764_97289960 | 15.81 |
Gm5560 |
predicted pseudogene 5560 |
25034 |
0.17 |
chr13_60529748_60529960 | 15.79 |
Gm25000 |
predicted gene, 25000 |
445 |
0.82 |
chr18_39152444_39152628 | 15.73 |
Arhgap26 |
Rho GTPase activating protein 26 |
53225 |
0.15 |
chr6_22717194_22717351 | 15.73 |
Gm8927 |
predicted gene 8927 |
13836 |
0.16 |
chr5_116322637_116322998 | 15.69 |
B230112J18Rik |
RIKEN cDNA B230112J18 gene |
10457 |
0.12 |
chr1_59394623_59395231 | 15.65 |
Gm29016 |
predicted gene 29016 |
15997 |
0.18 |
chr4_62285978_62286211 | 15.64 |
Slc31a2 |
solute carrier family 31, member 2 |
355 |
0.85 |
chr17_60267150_60267583 | 15.63 |
Gm29051 |
predicted gene 29051 |
136491 |
0.05 |
chr9_45510972_45511192 | 15.60 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
79352 |
0.07 |
chr1_17145019_17145170 | 15.60 |
Gdap1 |
ganglioside-induced differentiation-associated-protein 1 |
268 |
0.91 |
chr3_128546488_128546865 | 15.55 |
Gm22293 |
predicted gene, 22293 |
6304 |
0.29 |
chr12_51002047_51002408 | 15.53 |
Gm40421 |
predicted gene, 40421 |
2646 |
0.28 |
chr3_159851998_159852454 | 15.50 |
Wls |
wntless WNT ligand secretion mediator |
3775 |
0.28 |
chr1_186988549_186988700 | 15.46 |
Gm19058 |
predicted gene, 19058 |
17980 |
0.13 |
chr2_51831341_51831505 | 15.45 |
Gm13492 |
predicted gene 13492 |
12854 |
0.2 |
chr6_51675419_51675570 | 15.45 |
Gm38811 |
predicted gene, 38811 |
35587 |
0.17 |
chr10_51153683_51154077 | 15.40 |
Gm26257 |
predicted gene, 26257 |
28419 |
0.22 |
chr1_96346717_96347057 | 15.38 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr13_47413823_47413988 | 15.37 |
Gm35733 |
predicted gene, 35733 |
52519 |
0.15 |
chr4_125545547_125545968 | 15.26 |
Mir692-2 |
microRNA 692-2 |
41008 |
0.15 |
chr3_40070102_40070729 | 15.22 |
Gm42785 |
predicted gene 42785 |
246838 |
0.02 |
chr9_45664891_45665443 | 15.20 |
Dscaml1 |
DS cell adhesion molecule like 1 |
7670 |
0.2 |
chr2_47334535_47334687 | 15.11 |
Gm25959 |
predicted gene, 25959 |
207373 |
0.03 |
chr14_85508520_85508926 | 15.08 |
Gm9264 |
predicted gene 9264 |
29697 |
0.26 |
chr5_111917735_111917930 | 15.07 |
Gm42488 |
predicted gene 42488 |
26403 |
0.22 |
chr13_84751407_84751558 | 15.04 |
Gm26913 |
predicted gene, 26913 |
60541 |
0.15 |
chr5_131645868_131646247 | 14.99 |
Gm43483 |
predicted gene 43483 |
3250 |
0.16 |
chr16_64069361_64069662 | 14.96 |
Gm49627 |
predicted gene, 49627 |
114381 |
0.07 |
chr1_82452012_82452232 | 14.94 |
Gm28940 |
predicted gene 28940 |
49376 |
0.12 |
chr7_34764925_34765127 | 14.90 |
Chst8 |
carbohydrate sulfotransferase 8 |
11214 |
0.21 |
chr3_16819794_16819956 | 14.88 |
Gm26485 |
predicted gene, 26485 |
3437 |
0.4 |
chr3_88205312_88205479 | 14.87 |
AI849053 |
expressed sequence AI849053 |
800 |
0.34 |
chr6_6163350_6163566 | 14.84 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
10493 |
0.26 |
chr11_43747463_43748363 | 14.83 |
Ttc1 |
tetratricopeptide repeat domain 1 |
69 |
0.98 |
chr14_66494008_66494166 | 14.79 |
Gm23899 |
predicted gene, 23899 |
97608 |
0.07 |
chr17_49044163_49044341 | 14.67 |
Gm44304 |
predicted gene, 44304 |
52181 |
0.14 |
chr4_11762140_11762451 | 14.66 |
Cdh17 |
cadherin 17 |
4102 |
0.26 |
chr12_88860370_88860732 | 14.62 |
Nrxn3 |
neurexin III |
65112 |
0.13 |
chr5_9703200_9703375 | 14.60 |
Grm3 |
glutamate receptor, metabotropic 3 |
21883 |
0.21 |
chr10_84822817_84823117 | 14.49 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
11779 |
0.2 |
chr14_75236389_75236560 | 14.44 |
Cpb2 |
carboxypeptidase B2 (plasma) |
5813 |
0.15 |
chr6_15397521_15397861 | 14.43 |
Gm25470 |
predicted gene, 25470 |
7290 |
0.26 |
chr13_29015675_29016011 | 14.42 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
450 |
0.87 |
chr7_49699721_49700100 | 14.36 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
59205 |
0.11 |
chr9_87883201_87883375 | 14.36 |
Gm25528 |
predicted gene, 25528 |
5299 |
0.28 |
chr9_15421773_15422369 | 14.34 |
Gm2517 |
predicted gene 2517 |
2543 |
0.17 |
chr13_83750227_83750397 | 14.32 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11449 |
0.12 |
chr2_40643950_40644201 | 14.32 |
Lrp1b |
low density lipoprotein-related protein 1B |
13313 |
0.29 |
chr8_83187429_83187678 | 14.32 |
Gm10645 |
predicted gene 10645 |
21383 |
0.16 |
chr15_60633071_60633348 | 14.31 |
Gm48946 |
predicted gene, 48946 |
37134 |
0.17 |
chr14_11960676_11960864 | 14.28 |
Gm3848 |
predicted gene 3848 |
20438 |
0.22 |
chr18_25377822_25377990 | 14.27 |
Gm16558 |
predicted gene 16558 |
13895 |
0.27 |
chr18_57704186_57704540 | 14.26 |
Gm44491 |
predicted gene, 44491 |
22549 |
0.17 |
chr18_88551110_88551268 | 14.25 |
Gm50401 |
predicted gene, 50401 |
58213 |
0.14 |
chr10_105096222_105096373 | 14.25 |
Gm25422 |
predicted gene, 25422 |
44038 |
0.14 |
chr5_81359614_81359973 | 14.17 |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
49768 |
0.18 |
chr1_81076306_81076601 | 14.16 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
497 |
0.88 |
chr1_59574324_59574829 | 14.11 |
Gm973 |
predicted gene 973 |
7820 |
0.15 |
chr13_29349395_29349902 | 14.07 |
Gm11364 |
predicted gene 11364 |
113028 |
0.07 |
chr15_31989572_31989923 | 14.05 |
Gm49285 |
predicted gene, 49285 |
60204 |
0.14 |
chr2_41498755_41498942 | 14.05 |
Lrp1b |
low density lipoprotein-related protein 1B |
290230 |
0.01 |
chr15_32172974_32173218 | 14.04 |
Tas2r119 |
taste receptor, type 2, member 119 |
4193 |
0.25 |
chr2_48629270_48629461 | 14.03 |
Gm13481 |
predicted gene 13481 |
172120 |
0.03 |
chr12_44403738_44404185 | 14.02 |
Gm48182 |
predicted gene, 48182 |
5829 |
0.21 |
chr13_84571404_84571594 | 14.01 |
Gm26913 |
predicted gene, 26913 |
119442 |
0.06 |
chr6_134888824_134888980 | 14.01 |
Gpr19 |
G protein-coupled receptor 19 |
1070 |
0.35 |
chr11_25715843_25716025 | 13.95 |
Gm23514 |
predicted gene, 23514 |
30794 |
0.22 |
chr5_85571496_85571691 | 13.93 |
Gm43567 |
predicted gene 43567 |
149181 |
0.05 |
chr15_57733651_57733876 | 13.89 |
9330154K18Rik |
RIKEN cDNA 9330154K18 gene |
4903 |
0.23 |
chr11_32001085_32001393 | 13.82 |
Nsg2 |
neuron specific gene family member 2 |
737 |
0.7 |
chrX_10010308_10010474 | 13.81 |
Gm5754 |
predicted gene 5754 |
1397 |
0.54 |
chr18_80811625_80811797 | 13.81 |
Gm47272 |
predicted gene, 47272 |
10536 |
0.19 |
chr18_43687992_43688219 | 13.80 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
332 |
0.9 |
chr12_33035439_33035619 | 13.78 |
Cdhr3 |
cadherin-related family member 3 |
17457 |
0.14 |
chr12_50190972_50191191 | 13.73 |
Gm40418 |
predicted gene, 40418 |
70772 |
0.14 |
chr9_45608539_45608970 | 13.71 |
Gm22069 |
predicted gene, 22069 |
26058 |
0.18 |
chr11_42000451_42000692 | 13.71 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
39 |
0.99 |
chr17_88763479_88763727 | 13.70 |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
10453 |
0.24 |
chr1_64409346_64409511 | 13.70 |
Gm25748 |
predicted gene, 25748 |
13094 |
0.22 |
chr1_6757654_6757828 | 13.68 |
St18 |
suppression of tumorigenicity 18 |
20166 |
0.24 |
chr1_165935347_165935547 | 13.68 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
436 |
0.79 |
chr5_9623115_9623489 | 13.64 |
Gm42455 |
predicted gene 42455 |
20695 |
0.24 |
chr12_50119925_50120076 | 13.62 |
Gm40418 |
predicted gene, 40418 |
309 |
0.95 |
chr2_6867417_6867601 | 13.61 |
Celf2 |
CUGBP, Elav-like family member 2 |
4463 |
0.23 |
chr15_41082521_41082910 | 13.60 |
Gm49524 |
predicted gene, 49524 |
84755 |
0.09 |
chr4_12620550_12620746 | 13.57 |
Gm37985 |
predicted gene, 37985 |
23260 |
0.27 |
chr3_22816068_22816221 | 13.55 |
Gm37889 |
predicted gene, 37889 |
3937 |
0.37 |
chr9_62181116_62181267 | 13.53 |
Glce |
glucuronyl C5-epimerase |
58536 |
0.09 |
chr12_39301586_39301824 | 13.52 |
Gm18591 |
predicted gene, 18591 |
92813 |
0.08 |
chr10_100022050_100022439 | 13.48 |
Kitl |
kit ligand |
6328 |
0.21 |
chr2_33616683_33616884 | 13.48 |
Gm38011 |
predicted gene, 38011 |
2385 |
0.25 |
chr1_169968566_169969463 | 13.39 |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
227 |
0.67 |
chr12_49945277_49945719 | 13.39 |
Gm7481 |
predicted gene 7481 |
103747 |
0.08 |
chr2_57597721_57598247 | 13.32 |
Gm13532 |
predicted gene 13532 |
31244 |
0.18 |
chr5_3405638_3405791 | 13.32 |
Cdk6 |
cyclin-dependent kinase 6 |
61402 |
0.09 |
chr4_23636552_23636896 | 13.32 |
Gm25978 |
predicted gene, 25978 |
9979 |
0.24 |
chr5_40295409_40295582 | 13.31 |
Gm2810 |
predicted pseudogene 2810 |
32943 |
0.24 |
chr9_37114956_37115270 | 13.30 |
Gm48716 |
predicted gene, 48716 |
3543 |
0.18 |
chr6_47229035_47229229 | 13.28 |
Cntnap2 |
contactin associated protein-like 2 |
15255 |
0.28 |
chr16_96673151_96673604 | 13.27 |
Gm49907 |
predicted gene, 49907 |
39007 |
0.15 |
chr1_85089758_85090158 | 13.23 |
Gm10553 |
predicted gene 10553 |
9554 |
0.09 |
chr17_82199078_82199482 | 13.18 |
Gm27359 |
predicted gene, 27359 |
5525 |
0.19 |
chr2_171847235_171847407 | 13.16 |
1700028P15Rik |
RIKEN cDNA 1700028P15 gene |
114810 |
0.06 |
chr1_84086467_84086780 | 13.15 |
Pid1 |
phosphotyrosine interaction domain containing 1 |
33370 |
0.18 |
chr4_85768203_85768551 | 13.10 |
Adamtsl1 |
ADAMTS-like 1 |
254050 |
0.02 |
chr7_54565770_54565921 | 13.10 |
Gm6290 |
predicted gene 6290 |
45353 |
0.19 |
chr8_48322987_48323138 | 13.09 |
Tenm3 |
teneurin transmembrane protein 3 |
22963 |
0.23 |
chr13_28416864_28417183 | 13.04 |
Gm40841 |
predicted gene, 40841 |
2840 |
0.33 |
chr17_88675649_88675800 | 13.03 |
Gtf2a1l |
general transcription factor IIA, 1-like |
7028 |
0.19 |
chr14_75473074_75473492 | 13.03 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
17301 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.2 | 87.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
8.1 | 24.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
6.4 | 19.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
5.4 | 16.3 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
5.4 | 16.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
5.4 | 21.5 | GO:0030035 | microspike assembly(GO:0030035) |
4.9 | 14.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
4.8 | 33.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
4.8 | 14.4 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
4.7 | 18.6 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.6 | 31.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
4.5 | 22.3 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
4.3 | 12.8 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
4.2 | 4.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
4.2 | 12.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
3.9 | 11.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.9 | 11.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
3.9 | 11.6 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
3.7 | 29.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
3.6 | 10.8 | GO:0001927 | exocyst assembly(GO:0001927) |
3.6 | 17.8 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
3.4 | 10.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
3.4 | 3.4 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
3.3 | 9.8 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
3.3 | 13.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
3.2 | 9.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
3.2 | 9.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.1 | 9.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
3.1 | 33.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
3.0 | 8.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.9 | 11.7 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.9 | 14.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.9 | 8.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.9 | 2.9 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
2.9 | 8.6 | GO:0031223 | auditory behavior(GO:0031223) |
2.8 | 11.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.7 | 10.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
2.6 | 7.9 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
2.6 | 12.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
2.6 | 10.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.5 | 20.3 | GO:0050957 | equilibrioception(GO:0050957) |
2.5 | 15.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
2.5 | 7.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.5 | 9.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.5 | 9.9 | GO:0060594 | mammary gland specification(GO:0060594) |
2.5 | 12.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
2.4 | 7.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.4 | 12.1 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
2.4 | 4.8 | GO:0021564 | vagus nerve development(GO:0021564) |
2.4 | 7.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.4 | 11.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.4 | 4.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.3 | 4.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.3 | 7.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
2.3 | 2.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.3 | 6.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.2 | 6.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.2 | 4.4 | GO:0060166 | olfactory pit development(GO:0060166) |
2.2 | 6.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.1 | 8.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.1 | 19.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.1 | 6.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.0 | 6.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
2.0 | 18.3 | GO:0071625 | vocalization behavior(GO:0071625) |
2.0 | 10.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
2.0 | 4.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.0 | 6.0 | GO:0030070 | insulin processing(GO:0030070) |
2.0 | 6.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.0 | 19.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
2.0 | 5.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.9 | 35.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.9 | 11.6 | GO:0022605 | oogenesis stage(GO:0022605) |
1.9 | 15.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.9 | 1.9 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
1.9 | 3.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.8 | 7.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.8 | 1.8 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.8 | 3.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.8 | 5.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.8 | 9.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.8 | 3.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.8 | 3.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.8 | 7.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.8 | 5.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.8 | 8.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.8 | 5.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.8 | 5.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.8 | 5.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.8 | 10.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.7 | 6.9 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.7 | 3.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.7 | 24.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.7 | 5.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.7 | 3.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.7 | 3.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.7 | 5.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.7 | 3.4 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.7 | 6.7 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
1.7 | 5.0 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.7 | 5.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.6 | 9.9 | GO:0097264 | self proteolysis(GO:0097264) |
1.6 | 4.9 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.6 | 19.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.6 | 3.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.6 | 3.2 | GO:0007412 | axon target recognition(GO:0007412) |
1.6 | 11.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.6 | 1.6 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.6 | 6.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.6 | 6.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.5 | 6.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.5 | 6.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.5 | 4.6 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
1.5 | 1.5 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.5 | 4.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.5 | 25.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.5 | 1.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.5 | 4.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.5 | 3.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.5 | 2.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.5 | 7.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.5 | 21.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.5 | 2.9 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.4 | 1.4 | GO:0035483 | gastric emptying(GO:0035483) |
1.4 | 4.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.4 | 4.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.4 | 5.7 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.4 | 5.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.4 | 4.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.4 | 4.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.4 | 4.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.4 | 4.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.3 | 4.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.3 | 5.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.3 | 18.4 | GO:0010842 | retina layer formation(GO:0010842) |
1.3 | 3.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.3 | 2.6 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.3 | 5.2 | GO:0051013 | microtubule severing(GO:0051013) |
1.3 | 6.5 | GO:0035989 | tendon development(GO:0035989) |
1.3 | 2.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.3 | 5.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.3 | 23.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.3 | 11.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.2 | 9.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.2 | 6.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.2 | 3.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.2 | 2.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.2 | 7.3 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.2 | 2.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.2 | 3.6 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.2 | 11.8 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
1.2 | 9.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.2 | 4.7 | GO:0030091 | protein repair(GO:0030091) |
1.2 | 1.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.2 | 9.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.2 | 4.6 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
1.1 | 2.3 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.1 | 4.6 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.1 | 3.4 | GO:0060676 | ureteric bud formation(GO:0060676) |
1.1 | 3.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.1 | 4.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.1 | 2.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.1 | 3.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.1 | 4.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.1 | 3.3 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.1 | 2.2 | GO:0060174 | limb bud formation(GO:0060174) |
1.1 | 5.6 | GO:0014028 | notochord formation(GO:0014028) |
1.1 | 7.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.1 | 1.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.1 | 14.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.1 | 2.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.1 | 4.4 | GO:0090427 | activation of meiosis(GO:0090427) |
1.1 | 2.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.1 | 2.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.1 | 1.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.1 | 55.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.0 | 5.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.0 | 2.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.0 | 3.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.0 | 2.0 | GO:0021544 | subpallium development(GO:0021544) striatum development(GO:0021756) |
1.0 | 5.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.0 | 2.0 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
1.0 | 2.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.0 | 70.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.0 | 6.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.0 | 5.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.0 | 2.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.0 | 2.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.0 | 3.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.9 | 4.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.9 | 3.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.9 | 2.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.9 | 3.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.9 | 2.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 0.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.9 | 2.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.9 | 0.9 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.9 | 2.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 1.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.9 | 3.6 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.9 | 3.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.9 | 2.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.9 | 5.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.9 | 2.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.9 | 2.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 2.7 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.9 | 1.8 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.9 | 2.7 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.9 | 0.9 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.9 | 0.9 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.9 | 1.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.9 | 1.7 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.9 | 1.7 | GO:0061055 | myotome development(GO:0061055) |
0.9 | 7.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.9 | 5.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.9 | 0.9 | GO:2000974 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.9 | 0.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.8 | 2.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.8 | 5.9 | GO:0060736 | prostate gland growth(GO:0060736) |
0.8 | 3.3 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.8 | 5.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.8 | 5.8 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.8 | 4.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.8 | 6.5 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.8 | 2.4 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.8 | 6.5 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.8 | 4.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.8 | 3.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.8 | 0.8 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.8 | 2.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.8 | 1.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.8 | 0.8 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.8 | 2.4 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.8 | 3.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.8 | 8.6 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.8 | 3.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.8 | 1.6 | GO:0021554 | optic nerve development(GO:0021554) |
0.8 | 2.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.8 | 6.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.8 | 3.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.8 | 7.6 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.8 | 1.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 3.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.7 | 2.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.7 | 3.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.7 | 3.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.7 | 1.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.7 | 1.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.7 | 1.5 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.7 | 0.7 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.7 | 5.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.7 | 1.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.7 | 1.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.7 | 5.7 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.7 | 2.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.7 | 1.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.7 | 1.4 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 2.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.7 | 2.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 1.4 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.7 | 3.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.7 | 1.4 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.7 | 2.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.7 | 1.4 | GO:0021794 | thalamus development(GO:0021794) |
0.7 | 2.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 3.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.6 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.6 | 13.3 | GO:0003407 | neural retina development(GO:0003407) |
0.6 | 2.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 2.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.6 | 1.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 2.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 0.6 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.6 | 2.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.6 | 2.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.6 | 5.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.6 | 1.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.6 | 17.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.6 | 0.6 | GO:0061743 | motor learning(GO:0061743) |
0.6 | 1.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.6 | 3.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.6 | 0.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.6 | 2.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.6 | 2.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 1.7 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.6 | 1.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.6 | 1.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.6 | 3.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.6 | 2.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.6 | 1.7 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 2.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.6 | 1.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.6 | 3.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.6 | 1.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.5 | 4.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.5 | 1.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.5 | 1.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.5 | 0.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.5 | 4.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 1.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.5 | 1.6 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.5 | 2.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 0.5 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.5 | 1.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.5 | 1.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 1.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 0.5 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.5 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 2.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.5 | 4.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.5 | 3.0 | GO:0071435 | potassium ion export(GO:0071435) |
0.5 | 2.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.5 | 1.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.5 | 1.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.5 | 1.0 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.5 | 3.9 | GO:0046541 | saliva secretion(GO:0046541) |
0.5 | 2.9 | GO:0001964 | startle response(GO:0001964) |
0.5 | 1.5 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.5 | 1.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.5 | 1.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.5 | 1.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 1.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 1.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.5 | 4.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 2.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 1.4 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.5 | 2.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 0.5 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 1.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.5 | 1.9 | GO:0060242 | contact inhibition(GO:0060242) |
0.5 | 3.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 2.3 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 1.4 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.5 | 2.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.5 | 1.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.5 | 4.6 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.5 | 3.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 1.9 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.5 | 0.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.5 | 2.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 0.9 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 | 1.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 0.4 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 1.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 2.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 5.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.4 | 1.7 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.4 | 0.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.4 | 0.4 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.4 | 1.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 2.5 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.4 | 6.7 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 0.8 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.4 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 2.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 1.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.4 | 0.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.4 | 5.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.4 | 0.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.4 | 1.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 0.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.4 | 1.6 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 1.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 3.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 2.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 1.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 1.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.4 | 0.8 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.4 | 2.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 1.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 0.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 1.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 1.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 1.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.4 | 0.7 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.4 | 1.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.4 | 3.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 1.1 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.4 | 2.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 1.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.4 | 1.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.4 | 4.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 0.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 0.4 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.4 | 5.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 1.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 2.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 1.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 2.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 1.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 1.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 3.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.3 | 1.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.3 | 0.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 6.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.3 | 0.7 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.4 | GO:0048840 | otolith development(GO:0048840) |
0.3 | 1.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 0.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 2.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 3.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 0.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.3 | 1.9 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.3 | 1.3 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 0.6 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.3 | 1.6 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.3 | 10.0 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.3 | 1.2 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 0.3 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.3 | 2.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 1.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 2.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 0.9 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 0.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 0.6 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 1.8 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.3 | 1.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.3 | 1.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 0.6 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 0.9 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 0.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 1.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.3 | 0.6 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.3 | 0.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 0.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 0.3 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.3 | 0.6 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.3 | 0.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 0.6 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.3 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 1.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 1.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.6 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) regulation of cardiac muscle cell membrane repolarization(GO:0099623) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.3 | 0.3 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.3 | 0.8 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 2.8 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 0.8 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.3 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 7.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 1.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 0.8 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.3 | 0.5 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.3 | 0.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 0.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 0.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 1.5 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 1.7 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.2 | 0.2 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.2 | 3.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 4.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 1.0 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 0.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.2 | 1.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.2 | GO:2000987 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.2 | 0.7 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.7 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.9 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.2 | 3.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.9 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.2 | 0.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.2 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 3.7 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 1.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.9 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.2 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.2 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.2 | 0.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 1.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 2.0 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 0.2 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 1.2 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 4.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 1.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 0.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.6 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.2 | 1.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 0.8 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 0.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 1.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 3.0 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 0.2 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.2 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 1.5 | GO:0097369 | sodium ion import(GO:0097369) |
0.2 | 0.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 0.5 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.2 | 0.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.5 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.2 | 0.8 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 1.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.2 | 0.3 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.2 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 1.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 0.3 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 1.9 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 3.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.7 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.9 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.6 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 2.2 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.5 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.6 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 1.4 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.1 | 1.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 2.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.8 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 1.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.8 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.9 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.8 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) |
0.1 | 0.5 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 0.2 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.9 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 1.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.5 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 3.5 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 1.0 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.6 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.1 | 0.6 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.1 | 0.3 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.2 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.0 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.0 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 1.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 45.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
3.9 | 11.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.4 | 24.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
3.1 | 55.3 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
3.0 | 8.9 | GO:0072534 | perineuronal net(GO:0072534) |
2.9 | 11.8 | GO:0033269 | internode region of axon(GO:0033269) |
2.9 | 34.6 | GO:0043194 | axon initial segment(GO:0043194) |
2.6 | 15.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.5 | 20.0 | GO:0043083 | synaptic cleft(GO:0043083) |
2.5 | 12.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.3 | 38.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.2 | 8.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.1 | 6.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.1 | 105.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
2.0 | 4.1 | GO:0097441 | basilar dendrite(GO:0097441) |
2.0 | 4.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.9 | 11.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.9 | 26.9 | GO:0043196 | varicosity(GO:0043196) |
1.7 | 43.6 | GO:0044295 | axonal growth cone(GO:0044295) |
1.7 | 8.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.6 | 4.8 | GO:0033010 | paranodal junction(GO:0033010) |
1.6 | 4.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.5 | 9.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.5 | 12.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.5 | 14.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.5 | 4.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.4 | 1.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.3 | 5.4 | GO:0042583 | chromaffin granule(GO:0042583) |
1.3 | 36.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.3 | 5.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.3 | 7.9 | GO:0032584 | growth cone membrane(GO:0032584) |
1.3 | 6.5 | GO:0097433 | dense body(GO:0097433) |
1.3 | 21.7 | GO:0005614 | interstitial matrix(GO:0005614) |
1.3 | 7.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
1.2 | 13.7 | GO:0031045 | dense core granule(GO:0031045) |
1.2 | 3.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.2 | 2.5 | GO:0005955 | calcineurin complex(GO:0005955) |
1.2 | 11.0 | GO:0030673 | axolemma(GO:0030673) |
1.2 | 5.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.1 | 5.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.1 | 46.7 | GO:0043198 | dendritic shaft(GO:0043198) |
1.1 | 12.8 | GO:0032426 | stereocilium tip(GO:0032426) |
1.1 | 2.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.0 | 8.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.0 | 4.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.0 | 4.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.0 | 3.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.9 | 3.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.9 | 6.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.9 | 3.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.9 | 4.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 3.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.9 | 4.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 4.8 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.8 | 2.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.8 | 6.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 2.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 3.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 2.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.8 | 2.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.8 | 0.8 | GO:0044393 | microspike(GO:0044393) |
0.7 | 5.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.7 | 1.5 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.7 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
0.7 | 2.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.7 | 2.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 6.3 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.7 | 4.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.7 | 2.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.7 | 5.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 2.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.7 | 2.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.7 | 4.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 3.8 | GO:0002177 | manchette(GO:0002177) |
0.6 | 1.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 7.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 1.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 3.4 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.6 | 1.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 1.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 4.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.5 | 6.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 2.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 67.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 1.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.5 | 4.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 1.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 1.8 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 0.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 3.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 1.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 6.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 3.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.4 | 59.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 6.2 | GO:0044298 | cell body membrane(GO:0044298) |
0.4 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 35.2 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.4 | 2.4 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 4.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 2.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 1.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 3.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 1.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.4 | 19.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 1.8 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 2.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 5.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 3.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 1.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 4.2 | GO:0043205 | fibril(GO:0043205) |
0.3 | 7.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 2.9 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 2.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 2.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 2.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 2.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 1.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 1.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 4.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 15.1 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 11.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 10.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 7.7 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 4.5 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 1.1 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.6 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 1.1 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 2.5 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.8 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 4.8 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0097060 | synaptic membrane(GO:0097060) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.6 | 61.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
16.4 | 49.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
10.3 | 30.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
4.8 | 24.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.6 | 9.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
3.8 | 11.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.7 | 14.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.5 | 13.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
3.3 | 16.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.2 | 16.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.2 | 9.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
3.2 | 3.2 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
3.1 | 9.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.0 | 9.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
3.0 | 11.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.9 | 55.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
2.9 | 26.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.8 | 11.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.8 | 16.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.8 | 2.8 | GO:0005167 | neurotrophin receptor binding(GO:0005165) neurotrophin TRK receptor binding(GO:0005167) |
2.7 | 10.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.5 | 30.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
2.5 | 7.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.5 | 7.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.5 | 7.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.5 | 22.1 | GO:0038191 | neuropilin binding(GO:0038191) |
2.2 | 8.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.1 | 6.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.0 | 6.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.9 | 5.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.9 | 7.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.9 | 5.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.8 | 12.6 | GO:0003680 | AT DNA binding(GO:0003680) |
1.7 | 10.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.7 | 10.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.7 | 13.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.7 | 6.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.6 | 6.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.5 | 4.6 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.5 | 4.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.5 | 7.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 4.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.4 | 5.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.4 | 33.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.4 | 2.8 | GO:0051425 | PTB domain binding(GO:0051425) |
1.4 | 5.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.4 | 4.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.3 | 5.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.3 | 7.9 | GO:0031419 | cobalamin binding(GO:0031419) |
1.3 | 5.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.3 | 25.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.2 | 19.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.2 | 3.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.2 | 3.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.2 | 4.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.2 | 9.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.2 | 7.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.1 | 3.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.1 | 5.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.1 | 3.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.1 | 3.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.1 | 23.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.0 | 4.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.0 | 3.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.0 | 4.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.0 | 3.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.0 | 1.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.0 | 3.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.0 | 4.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.0 | 13.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.9 | 14.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 18.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.9 | 10.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.9 | 4.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.9 | 1.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.9 | 2.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.9 | 7.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 7.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 3.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.9 | 6.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.9 | 1.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 3.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.8 | 3.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 5.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.8 | 2.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.8 | 4.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.8 | 3.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.8 | 4.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.8 | 4.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.8 | 7.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.8 | 9.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 2.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.8 | 2.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.8 | 6.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.8 | 3.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.7 | 4.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.7 | 5.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 2.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.7 | 2.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 4.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.7 | 4.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 2.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.7 | 2.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.7 | 8.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 2.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.7 | 3.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.7 | 3.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.7 | 2.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 3.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 3.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 2.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 7.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.6 | 2.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.6 | 1.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 7.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.6 | 2.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.6 | 2.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 1.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 4.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.6 | 6.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 1.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.5 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 13.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.5 | 2.7 | GO:0070728 | leucine binding(GO:0070728) |
0.5 | 1.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 1.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 6.5 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 1.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 1.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 1.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 1.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 2.3 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 5.5 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.5 | 4.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 2.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 6.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 2.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 11.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 1.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 1.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 2.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 1.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 2.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 1.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 2.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 2.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 2.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 2.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 3.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 1.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 4.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 4.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.4 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 1.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 6.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 2.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 1.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 0.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 5.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 0.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 1.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 1.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 8.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 5.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 0.6 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 0.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 0.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 1.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 0.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 2.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 2.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 1.4 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.3 | 3.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 0.8 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 1.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 2.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 2.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 2.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 2.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 4.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 4.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 2.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 2.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 6.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 4.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 3.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 2.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 5.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 1.5 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.2 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.2 | 0.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.7 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 1.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 3.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 5.6 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 1.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.4 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 3.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 1.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 1.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.7 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 1.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.9 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.9 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 2.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 1.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 1.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.9 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 1.0 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 1.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.0 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 1.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.3 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 0.1 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.0 | 0.6 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 55.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.1 | 3.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.9 | 2.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.8 | 1.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.7 | 2.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 14.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 9.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 8.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 10.8 | ST ADRENERGIC | Adrenergic Pathway |
0.4 | 12.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 12.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 1.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 24.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 4.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 8.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 8.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 2.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 5.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 5.5 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 3.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 4.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 43.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.0 | 41.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.5 | 2.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
2.4 | 63.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.1 | 22.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.1 | 16.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.6 | 15.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.4 | 1.4 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
1.4 | 25.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 9.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.3 | 21.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.2 | 13.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.2 | 9.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.0 | 3.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.9 | 19.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 5.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.9 | 12.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 9.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.8 | 17.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.7 | 0.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.7 | 14.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.7 | 12.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.6 | 25.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.6 | 5.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.6 | 11.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 3.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 2.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 7.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 23.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 7.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 16.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 0.9 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.4 | 4.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 5.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 5.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.4 | 13.1 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.4 | 4.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 14.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 2.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 3.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 4.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 3.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 1.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 1.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 3.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 0.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 2.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 8.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 0.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 4.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 1.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.2 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 1.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 1.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 3.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 4.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.4 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |